Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy
Ada Bertoli(IRCCS Policlinico San Donato), Alessia Ciancio(Department of Medical Sciences), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Adriano Pellicelli(Carlo Forlanini Hospital), Giuliano Rizzardini, Elisabetta Teti(University of Rome Tor Vergata), Laura Ambra Nicolini(Ospedale Policlinico San Martino), Loredana Sarmati(University of Rome Tor Vergata), Matteo Bolis(Ospedale Amedeo di Savoia), Bianca Bruzzone(Ospedale Policlinico San Martino), Vincenza Calvaruso(University of Palermo), Stefania Paolucci(Policlinico San Matteo Fondazione), M. Aragri(University of Rome Tor Vergata), V. Boccaccio(Humanitas University), Nicola Caporaso(Federico II University Hospital), C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), Sergio Babudieri(University of Sassari), Fausto Baldanti(University of Pavia), Ilaria Lenci, Ennio Polilli(Azienda USL di Pescara), Giorgio Barbarini(Humanitas University), Gloria Taliani(Sapienza University of Rome), Vanni Borghi(University of Modena and Reggio Emilia), M. Angélico, Chiara Masetti(NHS Blood and Transplant), Massimo Andreoni(University of Rome Tor Vergata), M.C. Sorbo(University of Rome Tor Vergata), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Velia Chiara Di Maio(University of Rome Tor Vergata), Francesca Ceccherini‐Silberstein(University of Cologne), Antonio Ciaccio(University of Turin), Pietro Andreoné, Giustino Parruti(Azienda USL di Pescara), Lucio Boglione(Ospedale Amedeo di Savoia), Elisa Biliotti(Sapienza University of Rome), Savino Bruno(Humanitas University), N. Iapadre(San Salvatore Hospital), Carlo Federico Perno(Centre International De Reference Chantal Biya), Antonio Craxı̀(University of Palermo), Stefano Bonora(Ospedale Amedeo di Savoia), Martina Milana(University of Rome Tor Vergata), Giuseppina Brancaccio, Laura Gianserra(Azienda Ospedaliera Sant'Andrea), Valeria Pace Palitti(Azienda USL di Pescara), C. Magni(ASST Fatebenefratelli Sacco), Massimo Siciliano(Università Cattolica del Sacro Cuore), Filomena Morisco, Pierluigi Cacciatore(Azienda USL di Pescara), Valeria Cento(Rostov State Medical University)
Cited by 48
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821